The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients
Abstract
Background: The natural history of multiple endocrine neoplasia type 1 (MEN1) is known through single‐institution or single‐family studies. We aimed to analyze the risk factors and causes of death in a large cohort of MEN1 patients. Methods: Overall, 758 symptomatic MEN1 patients were identified through the GTE network (Groupe d’étude des Tumeurs Endocrines), which involves French and Belgian genetics laboratories responsible for MEN1 diagnosis and 80 clinical reference centers. The causes of death were analyzed. A frailty model, including time‐dependent variables, was used to assess the impact of each clinical lesion, except for hyperparathyroidism, on survival. Results: The median follow‐up was 6.3 years. Female gender, family history of MEN1, and recent diagnosis were associated with a lower risk of death. Compared with nonaffected patients, those with thymic tumors (hazard ratio [HR] = 4.64, 95% CI = 1.73‐12.41), glucagonomas–vipomas–somatostatinomas (HR = 4.29, 95% CI = 1.54‐11.93), nonfunctioning pancreatic tumors (HR = 3.43, 95% CI = 1.71‐6.88), and gastrinoma (HR = 1.89, 95% CI = 1.09‐3.25) had a higher risk of death after adjustment for age, gender, and diagnosis period. The increased risk of death among patients with adrenal tumors was not significant, but three patients died from aggressive adrenal tumors. Pituitary tumors, insulinomas, and bronchial tumors did not increase the risk of death. The proportion of MEN1‐related deaths decreased from 76.8 to 71.4% after 1990. Conclusions: The prognosis of MEN1 disease has improved since 1980. Thymic tumors and duodenopancreatic tumors, including nonsecreting pancreatic tumors, increased the risk of death. Rare but aggressive adrenal tumors may also cause death. Most deaths were related to MEN1. New recommendations on abdominal and thoracic imaging are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Genetic aspects of adenomatosis of endocrine glands
Wermer, P. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90353-8 · Cited by 860
Lemmens, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1177 · Cited by 611
Cancer incidence and mortality in France over the period 1978-2000.
Remontet, L., Estève, J., Bouvier, A., Grosclaude, P., Launoy, G. D., Ménégoz, F., Exbrayat, C., Tretare, B., Carli, P.-M., Guizard, A., et al. (2003) · PubMed · Cited by 551
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8145 · Cited by 483
Self-citationAgarwal, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1169 · Cited by 477
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Trump, D., Farren, B., Wooding, C., Pang, J. T., Besser, G. M., Buchanan, K. D., Edwards, C. R., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · doi:10.1093/qjmed/89.9.653 · Cited by 471
Ekeblad, S., Skogseid, B., Dunder, K., Öberg, K., & Eriksson, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0734 · Cited by 360
Radiation Exposure at Chest CT: A Statement of the Fleischner Society
Mayo, J. R., Aldrich, J., & Müller, N. L. (2003) · Radiology · doi:10.1148/radiol.2281020874 · Cited by 359
de Leon, M. P. (1994) · Recent Results in Cancer Research · doi:10.1007/978-3-642-85076-9_7 · Cited by 260
Lethality of Multiple Endocrine Neoplasia Type I
Doherty, G. M., Olson, J. A., Frisella, M. M., Lairmore, T. C., Wells, S. A., & Norton, J. A. (1998) · World Journal of Surgery · doi:10.1007/s002689900438 · Cited by 252
Triponez, F., Dosseh, D., Goudet, P., Cougard, P., Bauters, C., Murat, A., Cadiot, G., Niccoli-Sire, P., Chayvialle, J.-A., Calender, A., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000197715.96762.68 · Cited by 251
Self-citationSurvival after the Diagnosis of Hyperparathyroidism: A Population-based Study
Wermers, R. A., Khosla, S., Atkinson, E. J., Grant, C. S., Hodgson, S. F., O’Fallon, W. M., & Melton, L. J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00270-2 · Cited by 251
Giraud, S., Zhang, C. X., Serova-Sinilnikova, O., Wautot, V., Salandre, J., Buisson, N., Waterlot, C., Bauters, C., Porchet, N., Aubert, J.-P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301953 · Cited by 211
Self-citationTriponez, F., Goudet, P., Dosseh, D., Cougard, P., Bauters, C., Murat, A., Cadiot, G., Niccoli‐Sire, P., Calender, A., & Proye, C. A. G. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0354-9 · Cited by 209
Self-citationAre Patients with Multiple Endocrine Neoplasia Type I Prone to Premature Death?
Dean, P. G., van Heerden, J. A., Farley, D. R., Thompson, G. B., Grant, C. S., Harmsen, W. S., & Ilstrup, D. M. (2000) · World Journal of Surgery · doi:10.1007/s002680010237 · Cited by 194
Multiple endocrine neoplasia type 1
Marini, F., Falchetti, A., Monte, F. D., Sala, S. C., Gozzini, A., Luzi, E., & Brandi, M. L. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-38 · Cited by 185
The Natural History of Multiple Endocrine Neoplasia Type 1: Highly Uncommon or Highly Unrecognized?
Shepherd, J. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410320017001 · Cited by 163
Adrenal involvement in multiple endocrine neoplasia type 1
Langer, P., Cupisti, K., Bartsch, D. K., Nies, C., Goretzki, P. E., Rothmund, M., & Röher, H. D. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6492-4 · Cited by 151 · cited 1×
“[26] who had already observed that adrenal enlargement may progress to highly aggressive ACC in MEN1 disease.”
BackgroundCause of Death in Multiple Endocrine Neoplasia Type 1
Wilkinson, S. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420180085016 · Cited by 151
Lévy-Bohbot, N., Merle, C. S., Goudet, P., et al. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95184-6 · Cited by 149
Self-citationGoudet, P., Murat, A., Cardot-Bauters, C., Émy, P., Baudin, É., Choplin, H., Chapuis, Y., Kraimps, J., Sadoul, J., Tabarin, A., et al. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-9980-y · Cited by 118
Self-citationAdrenal lesion in multiple endocrine neoplasia type 1
Skogseid, B., Rastad, J., Gobl, A., Larsson, C., Backlin, K., Juhlin, C., Åkerström, G., & Öberg, K. (1995) · Surgery · doi:10.1016/s0039-6060(05)80117-5 · Cited by 111
Changing Treatment Strategy for Gastrinoma in Patients with Zollinger‐Ellison Syndrome
Imamura, M., Komoto, I., & Ota, S. (2005) · World Journal of Surgery · doi:10.1007/s00268-005-0341-1 · Cited by 104
The MEA-I syndrome: an all or none phenomenon?
Majewski, J., & Wilson, S. D. (1979) · PubMed · Cited by 100
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.457 · Cited by 100
Multiple endocrine neoplasia syndromes
Lips, C. J. M., Vasen, H. F. A., & Lamers, C. B. H. W. (1984) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(84)80017-7 · Cited by 95
Cougard, P., Goudet, P., Peix, J. L., Henry, J. F., Sarfati, E., Proye, C. A. G., & Calender, A. (2000) · Annales de Chirurgie · doi:10.1016/s0001-4001(00)00112-4 · Cited by 44
Self-citationModeling recurrence in colorectal cancer.
Dancourt, V., Quantin, C., Abrahamowicz, M., Binquet, C., Alioum, A., & Faivre, J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.07.012 · Cited by 37
Self-citation
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Marotta, V., Zatelli, M. C., Sciammarella, C., Ambrosio, M. R., Bondanelli, M., Colao, A., & Faggiano, A. (2018) · Endocrine-Related Cancer · doi:10.1530/erc-17-0269 · Cited by 161
Metadata
- Authors
- Goudet, P., Murat, A., Binquet, C., Cardot‐Bauters, C., Costa, A., Ruszniewski, P., Niccoli, P., Ménégaux, F., Chabrier, G., Borson‐Chazot, F., Tabarin, A., Bouchard, P., Delemer, B., Beckers, A., & Bonithon‐Kopp, C.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2009-12
- Volume
- 34
- Issue
- 2
- Pages
- 249-255
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W1980438381
- Cited by
- 350
- References
- 30
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.